An Internet Mediated Research Study to Assess the Quality of Life of Consumers With Self-reported Fungal Nail Infection (Onychomycosis) During Treatment With Scholl Fungal Nail.

Phase

N/A

Condition

Toenail Fungus (Onychomycosis)

Treatment

N/A

Clinical Study ID

NCT04084782

NPD89101

Ages > 18
All Genders

Study Summary

To evaluate the effect on quality of life of consumers with self-reported onychomycosis during the first 4 weeks of treatment in relation to the appearance of the infected toenail.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Aged 18 years or older
Consumers who have purchased the product online
Consumers who are willing to participate in the study

Exclusion

Exclusion Criteria:

Female consumers who are pregnant or breast feeding
Participants with Diabetes (Type I or II)

Study Design

August 13, 2019

December 31, 2019

Study Description

The appearance of the infected toe nail in those suffering from the disease may have a greater impact on quality of life than the severity of the disease. It is believed that a visual improvement in the appearance of the infected toenail at an earlier stage could have a positive impact on quality of life and encourage compliance with treatment. The aim of this consumer study is to evaluate the quality of life of consumers with onychomycosis and investigate its relation to the appearance of the infected toenail within the initial 4 weeks of treatment with Scholl Fungal Nail following its purchase from an eCommerce platform.

Connect with a study center

RB Health
Hull, East Yorkshire HU78DS
United Kingdom
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.